
No transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2025-09-25 | Lisa McClain(R-MI09) | house | Sale | $1,001 - $15,000 |
| 2025-09-11 | Lisa McClain(R-MI09) | house | Purchase | $1,001 - $15,000 |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $2.16B+13.9% | $1.90B+3.4% | $1.84B+6.6% | $1.72B |
| Cost of services, exclusive of depreciation and amortization | $1.55B+13.0% | $1.37B+3.5% | $1.33B+6.7% | $1.24B |
| General and administrative, exclusive of depreciation and amortization | $203.3M+30.1% | $156.3M+2.8% | $152.0M+1.3% | $150.0M |
| Depreciation and amortization | $75.8M+12.9% | $67.2M-8.0% | $73.1M-0.8% | $73.7M |
| Total costs and expenses | $1.83B+14.6% | $1.60B+2.9% | $1.55B+5.8% | $1.47B |
| Other operating income | $20K-93.0% | $284K+13.6% | $250K-19.9% | $312K |
| Income from operations | $334.0M+9.6% | $304.8M+6.0% | $287.6M+11.3% | $258.5M |
| Loss on early retirement of debt | -$875K | $0 | $0 | — |
| Equity in losses of unconsolidated subsidiaries | $0+100.0% | -$3.7M-598.9% | -$526K+66.6% | -$1.6M |
| Interest expense | -$109.3M-129.1% | -$47.7M-21490.0% | -$221K+74.0% | -$849K |
| Other expense | $0 | $0+100.0% | -$2K+99.5% | -$415K |
| Income before income taxes | $223.8M-3.3% | $231.4M-4.6% | $242.6M+7.9% | $224.9M |
| Income tax expense | $51.0M-14.3% | $59.5M+2.8% | $57.9M+9.9% | $52.7M |
| Net income | $172.8M+0.6% | $171.9M-7.0% | $184.7M+7.3% | $172.2M |
| Less: net income attributable to non-controlling interests | $6.4M+20.2% | $5.4M+11.6% | $4.8M-13.1% | $5.5M |
| Net income attributable to the Company | $166.4M-0.1% | $166.5M-7.4% | $179.9M+7.9% | $166.7M |
| Basic (in dollars per share) | $1K-11.0% | $1K-15.6% | $2K+8.1% | $2K |
| Diluted (in dollars per share) | $1K-11.0% | $1K-15.6% | $2K+8.1% | $2K |
| Related Party | ||||
| Interest expense on related party debt | $0+100.0% | -$22.0M+50.3% | -$44.3M-43.7% | -$30.8M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Biodesix, Inc. (BDSX) Reports Q1 Loss, Tops Revenue Estimates
CON vs. COR: Which Stock Is the Better Value Option?
Concentra Group Holdings Parent, Inc. (CON) Shareholder/Analyst Call Prepared Remarks Transcript
Are Options Traders Betting on a Big Move in Concentra Group Stock?